SGLT2 Inhibitors Reduce Osteoarthritis, Surgery Risks in T2D SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Compared with #GLP1RAs, #SGTL2Inhibitors were associated with reduced risks for #osteoarthritis and #JointReplacementSurgery among patients with #T2D.